Bharat Biotech chief Krishna Ella given Y category security cover

Published On 2021-07-01 06:45 GMT   |   Update On 2021-07-01 13:02 GMT

New Delhi: Krishna Ella, the chairman of vaccine manufacturer Bharat Biotech, has recently been provided a "Y" category armed security cover by the Union government, officials said on Tuesday.

Ella, 52, is also the founder of the Hyderabad-based biotechnology company that is manufacturing the Covaxin vaccine approved by India for inoculation against COVID-19.

The company is also engaged in drug discovery, drug development, manufacturing various other vaccines, bio-therapeutics, pharmaceuticals and healthcare products.

The officials said Ella was provided the security cover of Central Industrial Security Force (CISF) armed commandos sometime ago given his current profile of spearheading the production of life-saving vaccines and other medical essentials.

About two-three commandos will accompany him whenever he travels to any part of the country under the "Y" category central cover, they said.

The premises of the Bharat Biotech International Limited (BBIL) in the Shameerpet area of Telangana''s capital Hyderabad was recently accorded an armed protection cover by the same paramilitary force following approval by the Union home ministry.

"In light of the increased threat perception to the biotechnology company, BBIL is inherently vulnerable to threats from anti-nationals and saboteurs. The CISF will provide a round-the-clock armed security cover to the facility in Hyderabad," a spokesperson of the force had then said.

In April, the Union government had similarly accorded a "Y" category security cover to Adar Poonawalla, the CEO and promoter of the Pune-based Serum Institute of India (SII) that manufactures the Covishield vaccine.

Read also: Bharat Biotech Covaxin rolling data to start in July: WHO



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News